Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial (Q46105061)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 February 2013

Language	Label	Description	Also known as
English	Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial	scientific article published on 26 February 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

phase III clinical trial

0 references

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

levodopa/carbidopa

1 reference

based on heuristic

inferred from title

Alberto J. Espay

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

Robert A Hauser

1

object named as

Robert A Hauser

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

author name string

Ann Hsu

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

Sherron Kell

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

Kapil Sethi

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

Mark Stacy

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

William Ondo

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

Martin O'Connell

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

Suneel Gupta

9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

IPX066 ADVANCE-PD investigators

10

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

publication date

26 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

Lancet Neurology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

12

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

346-356

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

Medical management of levodopa-associated motor complications in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of Parkinson's disease and its pharmacologic treatment on quality of life and economic outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Parkinson's disease symptoms: the patient's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled-release Sinemet (CR-4): a double-blind crossover study in patients with fluctuating Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic Parkinson's disease with controlled-release carbidopa/levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of Sinemet CR4 and standard Sinemet: double blind and long-term open trial in parkinsonian patients with fluctuations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind cross-over study of Sinemet-controlled release (CR4 50/200) versus Sinemet 25/100 in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind crossover comparison of Sinemet CR4 and standard Sinemet 25/100 in patients with Parkinson's disease and fluctuating motor performance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of controlled-release Sinemet (CR4) and standard Sinemet (25 mg/100 mg) in advanced Parkinson's disease: a double-blind, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison Between a Fast and a Slow Release Preparation of Levodopa and a Combination of the Two

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Impulse control disorders in adult psychiatric inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebral vascular accidents in patients over the age of 60. II. Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Duodenal levodopa infusion in Parkinson's disease--long-term experience

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent vs Continuous Levodopa Administration in Patients With Advanced Parkinson Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring therapy adherence in Parkinson's disease: a comparison of methods

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The scientific and clinical basis for the treatment of Parkinson disease (2009).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970025-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(13)70025-5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23485610

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46105061&oldid=2093164120"